Liquid chromatography-high resolution mass spectrometry with immunoaffinity clean-up for the determination of the oxidative stress biomarker 8-iso-prostaglandin F2alpha in wastewater.
暂无分享,去创建一个
[1] Christian G. Daughton,et al. Illicit Drugs in Municipal Sewage: Proposed New Nonintrusive Tool to Heighten Public Awareness of Societal Use of Illicit-Abused Drugs and Their Potential for Ecological Consequences , 2001 .
[2] L. Beilin,et al. Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid Peroxidation—A Comparison of Enzyme Immunoassay with Gas Chromatography/Mass Spectrometry , 1999 .
[3] R. Dinsdale,et al. Multi-residue method for the determination of basic/neutral pharmaceuticals and illicit drugs in surface water by solid-phase extraction and ultra performance liquid chromatography-positive electrospray ionisation tandem mass spectrometry. , 2007, Journal of chromatography. A.
[4] Trevor A. Mori,et al. A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates. , 2010, Analytical biochemistry.
[5] R. Cela,et al. Ion-pair reversed-phase liquid chromatography-quadrupole-time-of-flight and triple-quadrupole-mass spectrometry determination of ethyl sulfate in wastewater for alcohol consumption tracing. , 2014, Journal of chromatography. A.
[6] Ettore Zuccato,et al. A novel approach for monitoring tobacco use in local communities by wastewater analysis , 2014, Tobacco Control.
[7] Bing Li,et al. Direct rapid analysis of multiple PPCPs in municipal wastewater using ultrahigh performance liquid chromatography-tandem mass spectrometry without SPE pre-concentration. , 2012, Analytica chimica acta.
[8] P. Montuschi,et al. Isoprostanes: markers and mediators of oxidative stress , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] P. Stepnowski,et al. Simultaneous analysis of non-steroidal anti-inflammatory drugs and estrogenic hormones in water and wastewater samples using gas chromatography-mass spectrometry and gas chromatography with electron capture detection. , 2012, The Science of the total environment.
[10] T. Shokati,et al. Quantification of 15-F2t-isoprostane in human plasma and urine: results from enzyme-linked immunoassay and liquid chromatography/tandem mass spectrometry cannot be compared. , 2011, Rapid communications in mass spectrometry : RCM.
[11] U. Ceglarek,et al. Liquid chromatography-tandem mass spectrometry for the analysis of eicosanoids and related lipids in human biological matrices: a review. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[12] Adrian Covaci,et al. Illicit drug consumption estimations derived from wastewater analysis: a critical review. , 2011, The Science of the total environment.
[13] D. Barceló,et al. Analysis of ethyl sulfate in raw wastewater for estimation of alcohol consumption and its correlation with drugs of abuse in the city of Barcelona. , 2014, Journal of chromatography. A.
[14] Ettore Zuccato,et al. Estimating Community Drug Abuse by Wastewater Analysis , 2008, Environmental health perspectives.
[15] Malcolm J. Reid,et al. What else can the analysis of sewage for urinary biomarkers reveal about communities? , 2011, Environmental science & technology.
[16] J. Morrow,et al. F2-Isoprostanes as markers of oxidative stress in vivo: An overview , 2005, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[17] S. Basu. The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target , 2007, Scandinavian Journal of Food & Nutrition.
[18] J. Cracowski,et al. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. , 2002, Trends in pharmacological sciences.
[19] B. Matuszewski,et al. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.
[20] D. Tsikas,et al. Protocols for the measurement of the F2-isoprostane, 15(S)-8-iso-prostaglandin F2α, in biological samples by GC-MS or GC-MS/MS coupled with immunoaffinity column chromatography. , 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[21] B. Kasprzyk-Hordern,et al. Estimation of community-wide drugs use via stereoselective profiling of sewage. , 2012, The Science of the total environment.
[22] J. Morrow,et al. Quantification of F2-isoprostanes as a biomarker of oxidative stress , 2007, Nature Protocols.
[23] Nicholas A. Cellar,et al. Determination of F2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry. , 2010, Journal of agricultural and food chemistry.
[24] R. Cela,et al. Assessment of local tobacco consumption by liquid chromatography-tandem mass spectrometry sewage analysis of nicotine and its metabolites, cotinine and trans-3'-hydroxycotinine, after enzymatic deconjugation. , 2014, Analytical chemistry.
[25] Christoph Ort,et al. Comparing illicit drug use in 19 European cities through sewage analysis. , 2012, The Science of the total environment.
[26] Malcolm J Reid,et al. Analysis and interpretation of specific ethanol metabolites, ethyl sulfate, and ethyl glucuronide in sewage effluent for the quantitative measurement of regional alcohol consumption. , 2011, Alcoholism, clinical and experimental research.
[27] Christian G Daughton,et al. Using biomarkers in sewage to monitor community-wide human health: isoprostanes as conceptual prototype. , 2012, The Science of the total environment.
[28] Y. Lévi,et al. Estimation of illicit drugs consumption by wastewater analysis in Paris area (France). , 2010, Forensic science international.
[29] Ettore Zuccato,et al. Identification and measurement of illicit drugs and their metabolites in urban wastewater by liquid chromatography-tandem mass spectrometry. , 2006, Analytical chemistry.
[30] Á. Gil-Izquierdo,et al. A ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hour values in healthy volunteers in a controlled constant diet. , 2012, Rapid communications in mass spectrometry : RCM.
[31] G. FitzGerald,et al. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[32] I. Wilson,et al. UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. , 2006, Rapid communications in mass spectrometry : RCM.
[33] Christoph Ort,et al. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. , 2010, Environmental science & technology.
[34] P. Montuschi,et al. Insights into oxidative stress: the isoprostanes. , 2007, Current medicinal chemistry.
[35] Á. Gil-Izquierdo,et al. Assessment of oxidative stress markers and prostaglandins after chronic training of triathletes. , 2012, Prostaglandins & other lipid mediators.
[36] Ronny Blust,et al. Sewage epidemiology--a real-time approach to estimate the consumption of illicit drugs in Brussels, Belgium. , 2011, Environment international.
[37] D. Tsikas,et al. Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers , 2009, Critical reviews in clinical laboratory sciences.
[38] Barbara Kasprzyk-Hordern,et al. Illicit and pharmaceutical drug consumption estimated via wastewater analysis. Part A: chemical analysis and drug use estimates. , 2014, The Science of the total environment.
[39] D. Barceló,et al. Analysis of drugs of abuse and their human metabolites in water by LC-MS2: A non-intrusive tool for drug abuse estimation at the community level , 2008 .
[40] L. Wood,et al. A review of the methodology for assessing in vivo antioxidant capacity , 2006 .